| Product Name | NebuSelect™ Recombinant Mouse GIP, His-tag |
|---|---|
| Catalog Number | NBL-242580 |
| Alias/Synonyms | GIP; GIP; Incretin |
| Appearance | see COA |
| Molecule Weight | Glu22-Gln85 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | P48756 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242580-100ug | 100ug | Inquire | Inquire | |
| NBL-242580-1mg | 1mg | Inquire | Inquire | |
| NBL-242580-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse GIP, His-tag
Catalog#:
NBL-242580
Description:
NebuSelect™ Recombinant Mouse GIP, His-tag(Cat#NBL-242580) is expressed in HEK293 with His tag at the C-Terminus.It contains Glu22-Gln85.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 8.7 kDa. Due to glycosylation, the protein migrates to 13-18 kDa based on Bis-Tris PAGE result.
Target Name:
GIP; GIP; Incretin
Target Information:
The potential application of glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide, GIP) in the management of obesity and type 2 diabetes has been controversial. Initial interest in the therapeutic use of GIP was dampened by evidence that its insulinotropic activity was reduced in type 2 diabetes and by reports that it increased glucagon secretion and adipose deposition in non-diabetic individuals.
Amino Acid Sequence:
Glu22-Gln85
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.